FDA and the regulation of medical software

This paper traces the development of the Food and Drug Administration´s (FDA) regulation of computer software, as discrete products with medical applications as well as components of regulated medical devices. The earliest Agency deliberations of software are summarized, as are the Agency´s broad policy priorities and the concerns of developers, medical industries, and user communities over the potential scope and consequences of FDA regulation